Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GYRE THERAPEUTICS, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 170K | Nov 20, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GYRE | GYRE THERAPEUTICS, INC. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Chief Executive Officer, Director |
CBIO | GYRE THERAPEUTICS, INC. | Oct 30, 2023 | 0 | $0 | 3 | Nov 1, 2023 | Chief Executive Officer, Director |